Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology M&A Activity 2021

Feb 25, 2021

3535_iss_2021-02-25_4d0e156c-9e2c-4a4d-8bc4-a89debd631c6.html

M&A Activity

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA: Distribution agreement signed for New Zealand and Australia

Aqua Bio Technology ASA: Distribution agreement signed for New Zealand and Australia

25.2.2021 20:54:59 CET | Aqua Bio Technology ASA | Inside information

Aqua Bio Technology ASA (ABT) has today signed an exclusive distribution

agreement with Moana Active Skincare Limited for New Zealand and Australia. As

informed in the stock exchange announcement on 10 September 2020

[https://newsweb.oslobors.no/message/513213], ABT retains its local presence and

knowledge through the conclusion of an agreement with Moana Skincare New Zealand

Limited. The duration of the agreement is three years.

"We are pleased to have entered into an exclusive distribution agreement for New

Zealand and Australia. With this agreement, we are confident that the

continuation of marketing activities in the region will be taken care of. The

fact that the company's CEO is also a social entrepreneur in Downlights, a

company who works with people with Down syndrome and intellectual / learning

disabilities [https://www.downlightsnz.com/], adds an extra positive dimension

to the collaboration that ABT values, says Espen Kvale, CEO of Aqua Bio

Technology ASA.

"We are proud and enthusiastic to be able to continue and further develop Moana

Skincare and its position in New Zealand and Australia. Moana Skincare, as a

certified organic skin care series, is a series we are well acquainted with from

the past and will be important in Moana Active Skincare Limited's continued

growth in the region, "said Jennifer Del Bel, CEO of Moana Active Skincare

Limited.

For further information, please contact Espen Kvale, CEO, telephone +47 916 28

092

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

effective and they provide the cosmetics industry with natural alternatives to

traditional ingredients. ABT is also marketing and distributing natural skin

care products developed by partners towards consumers and professional users.

ABT's focus on commercialization and development of natural ingredients and

natural skin care products has been, and will continue to be, an important part

of the company's strategy going forward. Aqua Bio Technology is listed on

Euronext Expand.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

DISCLAIMER

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Espen Kvale, CEO, +47 916 28 092, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

* Download announcement as PDF.pdf

[https://kommunikasjon.ntb.no/ir-files/17847556/351/434/Download%20announceme

nt%20as%20PDF.pdf]